Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Ruiz

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Future Oncology (London, England)|January 18, 2020
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinomaMichael R Migden, Sunandana Chandra, Guilherme Rabinowits, et al.
Research Square|January 3, 2024
Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosisNicolas Coudray, Michelle C Juarez, Maressa C Criscito, et al.
Journal of the American Academy of Dermatology|October 19, 2025
Risk of recurrence, metastasis, and death for cutaneous squamous cell carcinomas with solitary large caliber perineural invasion: A multicenter cohort studyNina A Ran, Emily E Granger, Shlomo Koyfman, et al.
Oncogene|April 10, 2025
Hyperactivated YAP1 is essential for sustainable progression of renal clear cell carcinomaXiangmin Lv, Jiyuan Liu, Kazi Islam, et al.
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Kidney International Reports|May 22, 2026
Clinical Equipoise and Unimproved Outcomes following Posttransplant Cutaneous Squamous Cell CarcinomaTom H J Crisp, Emilia Peleva, Rachel Abbott, et al.
Journal of the American Academy of Dermatology|September 20, 2025
Impact of immunosuppression on cutaneous squamous cell carcinoma outcomesJason C Klein, Kathryn T Shahwan, Ursa Bezan Petric, et al.
NPJ Digital Medicine|February 15, 2025
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosisNicolas Coudray, Michelle C Juarez, Maressa C Criscito, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter studyEstella de Jong, Roel Genders, Catherine A Harwood, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Future Oncology (London, England)|January 18, 2020
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinomaMichael R Migden, Sunandana Chandra, Guilherme Rabinowits, et al.
Research Square|January 3, 2024
Self-supervised artificial intelligence predicts recurrence, metastasis and disease specific death from primary cutaneous squamous cell carcinoma at diagnosisNicolas Coudray, Michelle C Juarez, Maressa C Criscito, et al.
Journal of the American Academy of Dermatology|October 19, 2025
Risk of recurrence, metastasis, and death for cutaneous squamous cell carcinomas with solitary large caliber perineural invasion: A multicenter cohort studyNina A Ran, Emily E Granger, Shlomo Koyfman, et al.
Oncogene|April 10, 2025
Hyperactivated YAP1 is essential for sustainable progression of renal clear cell carcinomaXiangmin Lv, Jiyuan Liu, Kazi Islam, et al.
Journal of the American Academy of Dermatology|February 26, 2025
Identifying the impact of minor risk factors in Brigham and Women's Hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: A retrospective cohort studyKathryn T Shahwan, Trent D Walker, Andrea Tan, et al.
American Journal of Clinical Dermatology|September 25, 2025
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell CarcinomaLindsey M Voller, Kelsey E Hirotsu, Sumaira Z Aasi, et al.
Kidney International Reports|May 22, 2026
Clinical Equipoise and Unimproved Outcomes following Posttransplant Cutaneous Squamous Cell CarcinomaTom H J Crisp, Emilia Peleva, Rachel Abbott, et al.
Journal of the American Academy of Dermatology|September 20, 2025
Impact of immunosuppression on cutaneous squamous cell carcinoma outcomesJason C Klein, Kathryn T Shahwan, Ursa Bezan Petric, et al.
NPJ Digital Medicine|February 15, 2025
Self supervised artificial intelligence predicts poor outcome from primary cutaneous squamous cell carcinoma at diagnosisNicolas Coudray, Michelle C Juarez, Maressa C Criscito, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter studyEstella de Jong, Roel Genders, Catherine A Harwood, et al.
Pageof 3